Overview
Combining altered states of consciousness with talk therapy, Psychedelic-assisted therapies (PAT) represent a paradigm shift in the treatment of mental health disorders.
Emerging evidence indicates a potential for PAT to offer a much-needed alternative for many Australians who suffer from treatment-resistant conditions.
Phase 3 clinical evidence is necessary before widespread use can be endorsed, and while several Australian trials are underway, based on current progress, PAT is likely to receive approval for limited applications in 2023.
In this activity, you will explore current evidence, underlying mechanisms, protocols for administration and ethical challenges. Given the complex ethical, legal, medical, and psychological issues of PAT, access to evidence-based training for psychologists will be paramount.
For those who wish to stay informed on the topic, a link to the relevant APS interest group is provided within the activity in addition to other recommended readings and resources.
This activity comprises of an overview and four topics:
-
Theory,
-
Evidence,
-
Practicalities, and
-
Ethics.
A minimum of 1.5 hours is required for completion, including a final quiz which requires an 80% pass rate to unlock your certificate of completion.
Level of learning
Foundational. This activity is targeted to those new to the topic.
Duration of access
Access to this eLearning activity is for 6 months from the date of confirmed registration.
APS CPD-Approved
This activity has been assessed against the APS Standards for CPD activities and approved for its education quality. Learn more about the APS CPD Approval process.
CPD Frequently Asked Questions
Refer to the APS CPD Frequently Asked Questions for general and technical information when undertaking APS Professional development activities.